Literature DB >> 20577880

PET/CT in primary musculoskeletal tumours: a step forward.

A Lakkaraju1, C N Patel, K M Bradley, A F Scarsbrook.   

Abstract

Hybrid imaging with combined positron emission tomography/computed tomography (PET/CT) plays an important role in the staging and management of a wide variety of solid tumours. However, its use in the evaluation of musculoskeletal malignancy has not yet entered routine clinical practice. Cross-sectional imaging with magnetic resonance imaging (MR) and computed tomography have well-established roles but there is increasing evidence for the selective use of PET/CT in the management of these patients. The aims of this article are to review the current evidence and clinical applications of PET/CT in primary musculoskeletal tumours and discuss potential future developments using novel PET tracers and integrated PET/MR.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20577880     DOI： 10.1007/s00330-010-1862-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


  89 in total

1.  Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose.

Authors:  F Dehdashti; B A Siegel; L K Griffeth; M J Fusselman; D D Trask; A H McGuire; D J McGuire
Journal:  Radiology       Date:  1996-07       Impact factor: 11.105

2.  Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.

Authors:  Cristina Nanni; Elena Zamagni; Mohsen Farsad; Paolo Castellucci; Patrizia Tosi; Delia Cangini; Eugenio Salizzoni; Romeo Canini; Michele Cavo; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-02-02       Impact factor: 9.236

3.  F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

Authors:  Twyla B Bartel; Jeff Haessler; Tracy L Y Brown; John D Shaughnessy; Frits van Rhee; Elias Anaissie; Terri Alpe; Edgardo Angtuaco; Ronald Walker; Joshua Epstein; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

4.  Respiratory gating enhances imaging of pulmonary nodules and measurement of tracer uptake in FDG PET/CT.

Authors:  Matthias K Werner; J Anthony Parker; Gerald M Kolodny; Jeffrey R English; Matthew R Palmer
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

5.  Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

Authors:  Andrea Baur-Melnyk; Sonja Buhmann; Christoph Becker; Stefan Oswald Schoenberg; Nicola Lang; Reiner Bartl; Maximilian Ferdinand Reiser
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

6.  Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.

Authors:  Gi Jeong Cheon; Min Suk Kim; Jun Ah Lee; Soo-Yong Lee; Wan Hyeong Cho; Won Seok Song; Jae-Soo Koh; Ji Young Yoo; Dong Hyun Oh; Duk Seop Shin; Dae-Geun Jeon
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057

7.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

8.  Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG.

Authors:  Ora Israel; Maya Mor; Diana Gaitini; Zohar Keidar; Luda Guralnik; Ahuva Engel; Alex Frenkel; Rachel Bar-Shalom; Abraham Kuten
Journal:  J Nucl Med       Date:  2002-09       Impact factor: 10.057

9.  18FDG PET scanning of benign and malignant musculoskeletal lesions.

Authors:  Frieda Feldman; Ronald van Heertum; Chitra Manos
Journal:  Skeletal Radiol       Date:  2003-03-11       Impact factor: 2.199

Review 10.  An integrated MR/PET system: prospective applications.

Authors:  Heinz-Peter Schlemmer; Bernd J Pichler; Robert Krieg; Wolf-Dieter Heiss
Journal:  Abdom Imaging       Date:  2009-11
View more
  10 in total

Review 1.  Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.

Authors:  Giorgio Treglia; Marco Salsano; Antonella Stefanelli; Maria Vittoria Mattoli; Alessandro Giordano; Lorenzo Bonomo
Journal:  Skeletal Radiol       Date:  2011-11-10       Impact factor: 2.199

Review 2.  Musculoskeletal imaging: current and future trends.

Authors:  Hassan Douis; Steven L J James; A Mark Davies
Journal:  Eur Radiol       Date:  2010-12-22       Impact factor: 5.315

3.  Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma.

Authors:  Caitlin Hurley; M Beth McCarville; Barry L Shulkin; Shenghua Mao; Jianrong Wu; Fariba Navid; Najat C Daw; Alberto S Pappo; Michael W Bishop
Journal:  Pediatr Blood Cancer       Date:  2016-04-15       Impact factor: 3.167

Review 4.  Advances in the treatment of neurofibromatosis-associated tumours.

Authors:  Andrew L Lin; David H Gutmann
Journal:  Nat Rev Clin Oncol       Date:  2013-08-13       Impact factor: 66.675

Review 5.  Desmoplastic fibroma of the scapula with fluorodeoxyglucose uptake on positron emission tomography: a case report and literature review.

Authors:  Taketo Okubo; Tsuyoshi Saito; Tatsuya Takagi; Tomoaki Torigoe; Yoshiyuki Suehara; Keisuke Akaike; Takashi Yao; Kazuo Kaneko
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

6.  The Role of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Assessing the Response to Neoadjuvant Treatment in Patients with Osteosarcoma.

Authors:  Carmelo Caldarella; Marco Salsano; Maria Antonietta Isgrò; Giorgio Treglia
Journal:  Int J Mol Imaging       Date:  2012-09-13

7.  The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma.

Authors:  Natale Quartuccio; Giorgio Treglia; Marco Salsano; Maria Vittoria Mattoli; Barbara Muoio; Arnoldo Piccardo; Egesta Lopci; Angelina Cistaro
Journal:  Radiol Oncol       Date:  2013-05-21       Impact factor: 2.991

8.  Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.

Authors:  Christiaan Schiepers; Magnus Dahlbom
Journal:  Eur Radiol       Date:  2010-12-21       Impact factor: 5.315

Review 9.  Imaging review of skeletal tumors of the pelvis--part I: benign tumors of the pelvis.

Authors:  Gandikota Girish; Karen Finlay; Yoav Morag; Catherine Brandon; Jon Jacobson; David Jamadar
Journal:  ScientificWorldJournal       Date:  2012-05-15

10.  Can Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Be Used As a Useful Method to Evaluate the Treatment Response to Neoadjuvant Therapy Combined With Sorafenib and Anti-VEGF in Children Diagnosed With Metastatical Bone Sarcoma?

Authors:  Nurdan Tacyildiz; Hikmet Gulsah Tanyildiz; Handan Ugur Dincaslan; Gulsan Yavuz; Emel Unal; Elgin Ozkan; Cigdem Soydal; Ozlem Kucuk; Yusuf Yildiz
Journal:  Iran J Pediatr       Date:  2016-03-05       Impact factor: 0.364
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.